Vident Advisory’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Vident Advisory’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,860	Closed	-$606K	–	1530
2024 Q1	$606K	Sell	1,860 -8,915	-83%	-$2.19M	0.01%	746
2023 Q4	$2.05M	Buy	10,775 +918	+9%	+$173K	0.05%	372
2023 Q3	$1.96M	Buy	+9,857	New	+$2.33M	0.06%	315

Other funds holding SWAV

Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

UWS

Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Vident Advisory's SWAV Position: Q2 2024 in Review

Vident Advisory sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 1,860 shares — an estimated $606K sold.

Vident Advisory first reported a position in SWAV in Q3 2023 and held it in 3 quarters. The position peaked at $2.05M in Q4 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

Vident Advisory reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Vident Advisory sold 1,860 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $606K.
Vident Advisory first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2023 and held it in 3 quarters.
Vident Advisory's Shockwave Medical, Inc. Common Stock position peaked at $2.05M in Q4 2023.
7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Vident Advisory's 13F filing for Q2 2024, filed 14 Aug 2024.